Clinical Trial Update: A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy [Phase 1]

View source ↗

Summary

Phase 1 study of ITC-6146RO in patients with advanced or metastatic cancers after standard therapy; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Non-small Cell Lung Cancer
• Solid Tumor
• Triple-negative Breast Cancer

Drugs mentioned

• ITC-6146RO

Snippet

Sponsor: IntoCell, Inc | Conditions: Metastatic Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer | Phase 1 | Status: NOT_YET_RECRUITING